Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.88 - $4.8 $17,729 - $29,548
-6,156 Reduced 33.68%
12,120 $38,000
Q4 2023

Feb 13, 2024

SELL
$3.46 - $5.33 $3,110 - $4,791
-899 Reduced 4.69%
18,276 $89,000
Q3 2023

Nov 13, 2023

SELL
$5.07 - $8.44 $20,315 - $33,819
-4,007 Reduced 17.28%
19,175 $104,000
Q2 2023

Aug 04, 2023

SELL
$6.19 - $8.78 $11,575 - $16,418
-1,870 Reduced 7.46%
23,182 $155,000
Q1 2023

May 11, 2023

BUY
$7.8 - $10.11 $20,677 - $26,801
2,651 Added 11.83%
25,052 $221,000
Q4 2022

Feb 07, 2023

SELL
$6.26 - $9.34 $14,523 - $21,668
-2,320 Reduced 9.38%
22,401 $171,000
Q3 2022

Nov 10, 2022

SELL
$6.5 - $12.67 $10,257 - $19,993
-1,578 Reduced 6.0%
24,721 $176,000
Q2 2022

Aug 03, 2022

BUY
$6.4 - $14.73 $49,779 - $114,569
7,778 Added 42.0%
26,299 $213,000
Q1 2022

May 04, 2022

SELL
$10.12 - $28.9 $280,172 - $800,096
-27,685 Reduced 59.92%
18,521 $257,000
Q4 2021

Feb 04, 2022

BUY
$25.17 - $36.85 $24,792 - $36,297
985 Added 2.18%
46,206 $1.3 Million
Q3 2021

Oct 07, 2021

BUY
$30.02 - $39.87 $4,923 - $6,538
164 Added 0.36%
45,221 $1.54 Million
Q2 2021

Aug 04, 2021

BUY
$32.22 - $44.59 $54,999 - $76,115
1,707 Added 3.94%
45,057 $1.84 Million
Q1 2021

May 04, 2021

BUY
$37.26 - $67.74 $483,336 - $878,723
12,972 Added 42.7%
43,350 $1.75 Million
Q4 2020

Feb 02, 2021

BUY
$45.01 - $65.47 $456,626 - $664,193
10,145 Added 50.14%
30,378 $1.8 Million
Q3 2020

Oct 09, 2020

BUY
$35.79 - $48.81 $417,168 - $568,929
11,656 Added 135.9%
20,233 $984,000
Q2 2020

Jul 08, 2020

BUY
$24.95 - $48.38 $213,996 - $414,955
8,577 New
8,577 $415,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.05B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.